Acute Cellular Rejection and the Subsequent Development of Allograft Vasculopathy After Cardiac Transplantation

Journal of Heart and Lung Transplantation

Volumn 28, Issue 4, 2009, Pages 320-327

  Raichlin, Eugenia ^a   Edwards, Brooks S ^a   Kremers, Walter K ^a   Clavell, Alfredo L ^a   Rodeheffer, Richard J ^a   Frantz, Robert P ^a   Pereira, Naveen L ^a   Daly, Richard C ^a   McGregor, Christopher G ^a   Lerman, Amir ^a   Kushwaha, Sudhir S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; DIAGNOSTIC IMAGING; FEMALE; HEART MUSCLE NECROSIS; HEART TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

ACUTE DISEASE; ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 62949130657     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.01.006     Document Type: Article

References (58)

1. Miller L.W., Schlant R.C., Kobashigawa J., Kubo S., and Renlund D.G. 24th Bethesda conference: cardiac transplantation. Task Force 5: complications. J Am Coll Cardiol 22 (1993) 41-54
2. Taylor D.O., Edwards L.B., Aurora P., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant 27 (2008) 943-956
3. Julius B.K., Attenhofer Jost C.H., Sutsch G., et al. Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation. Transplantation 69 (2000) 847-853
4. Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 17 (1998) 744-753
5. Billingham M.E. Histopathology of graft coronary disease. J Heart Lung Transplant 11 (1992) S38-S44
6. Russell M.E., Fujita M., Masek M.A., Rowan R.A., and Billingham M.E. Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation 56 (1993) 1599-1601
7. Hornick P., Smith J., Pomerance A., et al. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'early' transplant-associated coronary artery disease. Circulation 96 (1997) II-148-53
8. Jimenez J., Kapadia S.R., Yamani M.H., et al. Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study. J Heart Lung Transplant 20 (2001) 393-398
9. Brunner-La Rocca H.P., Schneider J., Kunzli A., Turina M., and Kiowski W. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease. Transplantation 65 (1998) 538-543
10. Caforio A.L., Tona F., Fortina A.B., et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 4 (2004) 962-970
11. Opelz G. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study. Transplant Proc 29 (1997) 73-76
12. Narrod J., Kormos R., Armitage J., Hardesty R., Ladowski J., and Griffith B. Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant 8 (1989) 418-420 discussion 20-1
13. Vassalli G., Gallino A., Weis M., et al. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 24 (2003) 1180-1188
14. Yamani M.H., Haji S.A., Starling R.C., et al. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. J Am Coll Cardiol 39 (2002) 970-977
15. Gao S.Z., Schroeder J.S., Hunt S.A., Valantine H.A., Hill I.R., and Stinson E.B. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant 12 (1993) 1029-1035
16. Stovin P.G., Sharples L.D., Schofield P.M., et al. Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-related coronary artery disease. J Heart Lung Transplant 12 (1993) 110-116
17. Billingham M.E. Cardiac transplant atherosclerosis. Transplant Proc 19 (1987) 19-25
18. Raichlin E., Khalpey Z., Kremers W., et al. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation 84 (2007) 467-474
19. Bae J.H., Rihal C.S., Edwards B.S., et al. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation 82 (2006) 1108-1111
20. Raichlin E., Bae J.H., Khalpey Z., et al. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 116 (2007) 2726-2733
21. Chaves A.J., Sousa A.G., Mattos L.A., et al. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial. Circulation 109 (2004) 861-866
22. Nair A., Kuban B.D., Tuzcu E.M., Schoenhagen P., Nissen S.E., and Vince D.G. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106 (2002) 2200-2206
23. Nair A., Kuban B.D., Obuchowski N., and Vince D.G. Assessing spectral algorithms to predict atherosclerotic plaque composition with normalized and raw intravascular ultrasound data. Ultrasound Med Biol 27 (2001) 1319-1331
24. DeMaria A.N., Narula J., Mahmud E., and Tsimikas S. Imaging vulnerable plaque by ultrasound. J Am Coll Cardiol 47 (2006) C32-C39
25. Nasu K., Tsuchikane E., Katoh O., et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47 (2006) 2405-2412
26. Tellides G., Tereb D.A., Kirkiles-Smith N.C., et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 403 (2000) 207-211
27. Mehra M.R., Ventura H.O., Chambers R.B., Ramireddy K., Smart F.W., and Stapleton D.D. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. J Heart Lung Transplant 16 (1997) 743-751
28. Yeoh T.K., Frist W.H., Eastburn T.E., and Atkinson J. Clinical significance of mild rejection of the cardiac allograft. Circulation 86 (1992) II267-II271
29. Lloveras J.J., Escourrou G., Delisle M.B., et al. Evolution of untreated mild rejection in heart transplant recipients. J Heart Lung Transplant 11 (1992) 751-756
30. Winters G.L., Loh E., and Schoen F.J. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?. Circulation 91 (1995) 1975-1980
31. Stoica S.C., Cafferty F., Pauriah M., et al. The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. J Heart Lung Transplant 25 (2006) 420-425
32. Dandel M., Hummel M., Wellnhofer E., Kapell S., Lehmkuhl H.B., and Hetzer R. Association between acute rejection and cardiac allograft vasculopathy. J Heart Lung Transplant 22 (2003) 1064-1065
33. Sharples L.D., Jackson C.H., Parameshwar J., Wallwork J., and Large S.R. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 76 (2003) 679-682
34. Billingham M., and Kobashigawa J.A. The revised ISHLT heart biopsy grading scale. J Heart Lung Transplant 24 (2005) 1709
35. Tang A.H., and Platt J.L. Accommodation of grafts: implications for health and disease. Hum Immunol 68 (2007) 645-651
36. Kirklin J.K., Bourge R.C., Naftel D.C., et al. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience. J Heart Lung Transplant 13 (1994) 444-450
37. Keogh A., Richardson M., Ruygrok P., et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 110 (2004) 2694-2700
38. Kaczmarek I., Ertl B., Schmauss D., et al. Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil. J Heart Lung Transplant 25 (2006) 550-556
39. Rigol M., Solanes N., Sionis A., et al. Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response. J Heart Lung Transplant 27 (2008) 416-422
40. Pethig K., Heublein B., Kutschka I., and Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation 102 (2000) III233-III236
41. Lawrence D.M., Singh R.S., Franklin D.P., Carey D.J., and Elmore J.R. Rapamycin suppresses experimental aortic aneurysm growth. J Vasc Surg 40 (2004) 334-338
42. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
43. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 25 (2006) 869-879
44. Kapadia S.R., Ziada K.M., L'Allier P.L., et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. J Heart Lung Transplant 19 (2000) 167-172
45. Klauss V., Rieber J., Uberfuhr P., Theisen K., and Mudra H. Qualitative and quantitative assessment of cardiac allograft vasculopathy by intravascular ultrasound. Transplant Proc 27 (1995) 1975-1976
46. Rickenbacher P.R., Pinto F.J., Lewis N.P., et al. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation 92 (1995) 3445-3452
47. White J.A., Pflugfelder P.W., Boughner D.R., and Kostuk W.J. Validation of a three-dimensional intravascular ultrasound imaging technique to assess atherosclerotic burden: potential for improved assessment of cardiac allograft coronary artery disease. Can J Cardiol 19 (2003) 1147-1153
48. Kobashigawa J.A., Miller L., Yeung A., et al. Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. Sandoz/CVIS Investigators. J Heart Lung Transplant 14 (1995) S221-S226
49. Valgimigli M., Rodriguez-Granillo G.A., Garcia-Garcia H.M., et al. Plaque composition in the left main stem mimics the distal but not the proximal tract of the left coronary artery: influence of clinical presentation, length of the left main trunk, lipid profile, and systemic levels of C-reactive protein. J Am Coll Cardiol 49 (2007) 23-31
50. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 108 (2003) 1772-1778
51. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108 (2003) 1664-1672
52. Arbustini E., and Roberts W.C. Morphological observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease). Am J Cardiol 78 (1996) 814-820
53. Raichlin E.R., McConnell J.P., Lerman A., et al. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant 26 (2007) 826-833
54. Labarrere C.A., Nelson D.R., and Spear K.L. Non-immunologic vascular failure of the transplanted heart. J Heart Lung Transplant 22 (2003) 236-240
55. Hognestad A., Endresen K., Wergeland R., et al. Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients. J Am Coll Cardiol 42 (2003) 477-482
56. Eisenberg M.S., Chen H.J., Warshofsky M.K., et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 102 (2000) 2100-2104
57. Jonas M., Fang J.C., Wang J.C., et al. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. J Am Coll Cardiol 48 (2006) 453-461
58. Lamich R., Ballester M., Marti V., et al. Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation. J Am Coll Cardiol 32 (1998) 413-419